| Published Application/Species/Sample/Dilution | Reference |
|---|
- western blot; human; 1:1000; loading ...; fig 1h
- western blot; mouse; 1:1000; loading ...; fig 1h
| Arendt K, Ntaliarda G, Armenis V, Kati D, Henning C, Giotopoulou G, et al. An In Vivo Inflammatory Loop Potentiates KRAS Blockade. Biomedicines. 2022;10: pubmed publisher |
- western blot; human; loading ...; fig 5b
| Lassiter R, Merchen T, Fang X, Wang Y. Protective Role of Kynurenine 3-Monooxygenase in Allograft Rejection and Tubular Injury in Kidney Transplantation. Front Immunol. 2021;12:671025 pubmed publisher |
- western blot; human; 1:1000; loading ...; fig 7a
| Shelton W, Thomas S, Alexander H, Thomes C, Conway D, Dubash A. Desmoglein-2 harnesses a PDZ-GEF2/Rap1 signaling axis to control cell spreading and focal adhesions independent of cell-cell adhesion. Sci Rep. 2021;11:13295 pubmed publisher |
- western blot; mouse; loading ...; fig 3g, 3h
| Li X, Huang K, Liu X, Ruan H, Ma L, Liang J, et al. Ellagic Acid Attenuates BLM-Induced Pulmonary Fibrosis via Inhibiting Wnt Signaling Pathway. Front Pharmacol. 2021;12:639574 pubmed publisher |
- western blot; mouse; 1:5000; loading ...; fig 8a
| Romeo R, Boden El Mourabit D, Scheller A, Mark M, Faissner A. Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) as a Novel Regulator of Early Astroglial Differentiation. Front Cell Neurosci. 2021;15:642521 pubmed publisher |
- western blot; dogs; 1:1000; loading ...; fig 5a
- western blot; human; 1:1000; loading ...; fig 5b
| Baek S, Lee S, Kim T, Choi S, Yun S, Lee W, et al. Senescence Marker Protein 30 (SMP30): A Novel Pan-Species Diagnostic Marker for the Histopathological Diagnosis of Breast Cancer in Humans and Animals. Int J Mol Sci. 2021;22: pubmed publisher |
- western blot; rat; 1:2000; loading ...; fig 9a
| Liu S, Flores J, Li B, Deng S, Zuo G, Peng J, et al. IL-20R Activation via rIL-19 Enhances Hematoma Resolution through the IL-20R1/ERK/Nrf2 Pathway in an Experimental GMH Rat Pup Model. Oxid Med Cell Longev. 2021;2021:5913424 pubmed publisher |
- western blot; rat; loading ...; fig s9b
| Cooper H, Cicalese S, Preston K, Kawai T, Okuno K, Choi E, et al. Targeting mitochondrial fission as a potential therapeutic for abdominal aortic aneurysm. Cardiovasc Res. 2021;117:971-982 pubmed publisher |
- western blot; human; 1:1000; fig 6b
| Yeom J, Ma S, Lim Y. Oxyresveratrol Induces Autophagy via the ER Stress Signaling Pathway, and Oxyresveratrol-Induced Autophagy Stimulates MUC2 Synthesis in Human Goblet Cells. Antioxidants (Basel). 2020;9: pubmed publisher |
- western blot; mouse; loading ...; fig s3b
- western blot; human; loading ...; fig s3b
| Sarek G, Kotsantis P, Ruis P, Van Ly D, Margalef P, Borel V, et al. CDK phosphorylation of TRF2 controls t-loop dynamics during the cell cycle. Nature. 2019;: pubmed publisher |
- western blot; human; 1:1000; loading ...; fig 3c
| Zhang L, Zheng C, Sun Z, Wang H, Wang F. Long non-coding RNA urothelial cancer associated 1 can regulate the migration and invasion of colorectal cancer cells (SW480) via myocardin-related transcription factor-A. Oncol Lett. 2019;18:4185-4193 pubmed publisher |
- western blot; human; 1:2000; loading ...; fig 6a
| Suo L, Chang X, Xu N, Ji H. The Anti-proliferative Activity of GnRH Through Downregulation of the Akt/ERK Pathways in Pancreatic Cancer. Front Endocrinol (Lausanne). 2019;10:370 pubmed publisher |
- western blot; human; loading ...; fig s3a
| Xu D, Li X, Shao F, Lv G, Lv H, Lee J, et al. The protein kinase activity of fructokinase A specifies the antioxidant responses of tumor cells by phosphorylating p62. Sci Adv. 2019;5:eaav4570 pubmed publisher |
- western blot; human; 1:5000; loading ...; fig 1c
| Jeong W, Park J, Kim W, Ro E, Jeon S, Lee S, et al. WDR76 is a RAS binding protein that functions as a tumor suppressor via RAS degradation. Nat Commun. 2019;10:295 pubmed publisher |
- western blot; human; 1:1000; loading ...; fig 1b
| Laurenzana A, Margheri F, Biagioni A, Chillà A, Pimpinelli N, Ruzzolini J, et al. EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cells. EBioMedicine. 2019;39:194-206 pubmed publisher |
- western blot; human; loading ...; fig 2e
| Lee S, Cho Y, Cha P, Yoon J, Ro E, Jeong W, et al. A small molecule approach to degrade RAS with EGFR repression is a potential therapy for KRAS mutation-driven colorectal cancer resistance to cetuximab. Exp Mol Med. 2018;50:153 pubmed publisher |
- western blot; human; loading ...; fig 6a
| Yang K, Chen Y, To K, Wang F, Li D, Chen L, et al. Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo. Exp Mol Med. 2017;49:e303 pubmed publisher |
- western blot; human; loading ...; fig 6A
| Chung C, Chang C, Hsu C, Lin K, Peng H, Huang T. Aggretin Venom Polypeptide as a Novel Anti-angiogenesis Agent by Targeting Integrin alpha2beta1. Sci Rep. 2017;7:43612 pubmed publisher |
- western blot; human; 1:200; loading ...; fig 2b
| Carpi S, Fogli S, Polini B, Montagnani V, Podestà A, Breschi M, et al. Tumor-promoting effects of cannabinoid receptor type 1 in human melanoma cells. Toxicol In Vitro. 2017;40:272-279 pubmed publisher |
- western blot; human; 1:2000; loading ...; fig 4a
| Peng Y, Shi X, Li Z, He X, Sun Y. Particularly interesting Cys-His-rich protein is highly expressed in human intracranial aneurysms and resists aneurysmal rupture. Exp Ther Med. 2016;12:3905-3912 pubmed publisher |
- western blot; human; 1:1500; loading ...; fig 4a
| Zhong W, Wang X, Pan B, Li F, Kuang L, Su Z. Eupatilin induces human renal cancer cell apoptosis via ROS-mediated MAPK and PI3K/AKT signaling pathways. Oncol Lett. 2016;12:2894-2899 pubmed |
- western blot; mouse; fig 3
| Jin Q, Ren Y, Wang M, Suraneni P, Li D, Crispino J, et al. Novel function of FAXDC2 in megakaryopoiesis. Blood Cancer J. 2016;6:e478 pubmed publisher |
- western blot; human; 1:1000; fig 4
| Shang W, Zhao L, Dong X, Zhao Z, Li J, Zhang B, et al. Curcumin inhibits osteoclastogenic potential in PBMCs from rheumatoid arthritis patients via the suppression of MAPK/RANK/c-Fos/NFATc1 signaling pathways. Mol Med Rep. 2016;14:3620-6 pubmed publisher |
- western blot; rat; loading ...; fig 10a
| Yang W, Yang Y, Yang J, Liang M, Song J. Treatment with bone marrow mesenchymal stem cells combined with plumbagin alleviates spinal cord injury by affecting oxidative stress, inflammation, apoptotis and the activation of the Nrf2 pathway. Int J Mol Med. 2016;37:1075-82 pubmed publisher |
- immunohistochemistry; mouse; 1:500; loading ...; fig 3d
- western blot; mouse; 1:500; loading ...; fig 3d
| Abdul Rahman N, Greenwood S, Brett R, Tossell K, Ungless M, Plevin R, et al. Mitogen-Activated Protein Kinase Phosphatase-2 Deletion Impairs Synaptic Plasticity and Hippocampal-Dependent Memory. J Neurosci. 2016;36:2348-54 pubmed publisher |
| Chinellato M, Gasparotto M, Quarta S, Ruvoletto M, Biasiolo A, Filippini F, et al. 1-Piperidine Propionic Acid as an Allosteric Inhibitor of Protease Activated Receptor-2. Pharmaceuticals (Basel). 2023;16: pubmed publisher |
| Montero J, Del Carmen S, Abad M, Sayagu xe9 s J, Barb xe1 chano A, Fern xe1 ndez Barral A, et al. An amino acid transporter subunit as an antibody-drug conjugate target in colorectal cancer. J Exp Clin Cancer Res. 2023;42:200 pubmed publisher |
| Cui S, Chen Y, Guo Y, Wang X, Chen D. Hsa-miR-22-3p inhibits liver cancer cell EMT and cell migration/ invasion by indirectly regulating SPRY2. PLoS ONE. 2023;18:e0281536 pubmed publisher |
| Kong Y, Allison D, Zhang Q, He D, Li Y, Mao F, et al. The kinase PLK1 promotes the development of Kras/Tp53-mutant lung adenocarcinoma through transcriptional activation of the receptor RET. Sci Signal. 2022;15:eabj4009 pubmed publisher |
| Cha Y, Kim T, Jeon J, Jang Y, Kim P, Lopes C, et al. SIRT2 regulates mitochondrial dynamics and reprogramming via MEK1-ERK-DRP1 and AKT1-DRP1 axes. Cell Rep. 2021;37:110155 pubmed publisher |
| Zhu G, Herlyn M, Yang X. TRIM15 and CYLD regulate ERK activation via lysine-63-linked polyubiquitination. Nat Cell Biol. 2021;23:978-991 pubmed publisher |
| Jung H, Choi D, Noh S, Choi H, Choi I, Ryu I, et al. New Benzimidazothiazolone Derivatives as Tyrosinase Inhibitors with Potential Anti-Melanogenesis and Reactive Oxygen Species Scavenging Activities. Antioxidants (Basel). 2021;10: pubmed publisher |
| Venkataraman B, Almarzooqi S, Raj V, Alhassani A, Alhassani A, Ahmed K, et al. Thymoquinone, a Dietary Bioactive Compound, Exerts Anti-Inflammatory Effects in Colitis by Stimulating Expression of the Colonic Epithelial PPAR-γ Transcription Factor. Nutrients. 2021;13: pubmed publisher |
| Fell S, Wang Z, Blanchard A, Nanthakumar C, Griffin M. Transglutaminase 2: a novel therapeutic target for idiopathic pulmonary fibrosis using selective small molecule inhibitors. Amino Acids. 2021;53:205-217 pubmed publisher |
| Hou S, Chen P, Lin C, Fang M, Chi M, Liu J. CXCL1 contributes to IL-6 expression in osteoarthritis and rheumatoid arthritis synovial fibroblasts by CXCR2, c-Raf, MAPK, and AP-1 pathway. Arthritis Res Ther. 2020;22:251 pubmed publisher |
| Qiang L, Yang S, Cui Y, He Y. Keratinocyte autophagy enables the activation of keratinocytes and fibroblasts and facilitates wound healing. Autophagy. 2020;:1-16 pubmed publisher |
| Gao J, Li Y, Yang X, Hu M, Xu J, Cheng L, et al. Changrui enema inhibits inflammation-induced angiogenesis in acute radiation proctitis by regulating NF-κB and VEGF. Acta Cir Bras. 2020;35:e202000502 pubmed publisher |
| Han S, Wei R, Zhang X, Jiang N, Fan M, Huang J, et al. CPT1A/2-Mediated FAO Enhancement-A Metabolic Target in Radioresistant Breast Cancer. Front Oncol. 2019;9:1201 pubmed publisher |
| Huang Y, Zhao J, Mao G, Lee G, Zhang J, Bi L, et al. Identification of novel genetic variants predisposing to familial oral squamous cell carcinomas. Cell Discov. 2019;5:57 pubmed publisher |
| Hepburn A, Steele R, Veeratterapillay R, Wilson L, Kounatidou E, Barnard A, et al. The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance. Oncogene. 2019;38:4412-4424 pubmed publisher |
| Knudsen E, Kumarasamy V, Ruiz A, Sivinski J, Chung S, Grant A, et al. Cell cycle plasticity driven by MTOR signaling: integral resistance to CDK4/6 inhibition in patient-derived models of pancreatic cancer. Oncogene. 2019;38:3355-3370 pubmed publisher |
| Sabbir M. Loss of Ca2+/Calmodulin Dependent Protein Kinase Kinase 2 Leads to Aberrant Transferrin Phosphorylation and Trafficking: A Potential Biomarker for Alzheimer's Disease. Front Mol Biosci. 2018;5:99 pubmed publisher |
| Breit A, Miek L, Schredelseker J, Geibel M, Merrow M, Gudermann T. Insulin-like growth factor-1 acts as a zeitgeber on hypothalamic circadian clock gene expression via glycogen synthase kinase-3β signaling. J Biol Chem. 2018;293:17278-17290 pubmed publisher |
| Dong P, Xiong Y, Yu J, Chen L, Tao T, Yi S, et al. Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4-miR-18a pathway in cervical cancer. Oncogene. 2018;37:5257-5268 pubmed publisher |
| Kaur H, He B, Zhang C, Rodriguez E, Hage D, Moreau R. Piperine potentiates curcumin-mediated repression of mTORC1 signaling in human intestinal epithelial cells: implications for the inhibition of protein synthesis and TNF? signaling. J Nutr Biochem. 2018;57:276-286 pubmed publisher |
| Ma R, Xu L, Qu X, Che X, Zhang Y, Fan Y, et al. AZ304, a novel dual BRAF inhibitor, exerts anti-tumour effects in colorectal cancer independently of BRAF genetic status. Br J Cancer. 2018;118:1453-1463 pubmed publisher |
| Ehlers K, Clements R, Vermeer M, Giles J, Tran Q. Novel regulations of the angiotensin II receptor type 1 by calmodulin. Biochem Pharmacol. 2018;152:187-200 pubmed publisher |
| Li X, Shang E, Dong Q, Li Y, Zhang J, Xu S, et al. Small molecules capable of activating DNA methylation-repressed genes targeted by the p38 mitogen-activated protein kinase pathway. J Biol Chem. 2018;293:7423-7436 pubmed publisher |
| Song Z, Liu F, Zhang J. Targeting NRASQ61K mutant delays tumor growth and angiogenesis in non-small cell lung cancer. Am J Cancer Res. 2017;7:831-844 pubmed |
| Cheng C, Zhou Y, Li H, Xiong T, Li S, Bi Y, et al. Whole-Genome Sequencing Reveals Diverse Models of Structural Variations in Esophageal Squamous Cell Carcinoma. Am J Hum Genet. 2016;98:256-74 pubmed publisher |
